Dr. Westin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Winter St
AbbVie (ImmunoGen)
Waltham, MA 02451Phone+1 781-895-0646
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1979 - 1982
UPMC Medical EducationResidency, Internal Medicine, 1976 - 1979
Albany Medical CollegeClass of 1976
Certifications & Licensure
VA State Medical License 1983 - 2026
MD State Medical License 2000 - 2025
WV State Medical License 1997 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 6 citationsPreclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.Juniper A Scribner, Stuart W Hicks, Kerstin W Sinkevicius, Nicholas C Yoder, Gundo Diedrich
Molecular Cancer Therapeutics. 2022-07-05 - 58 citationsA First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid MalignanciesDejan Juric, Johann S. de Bono, Patricia LoRusso, John Nemunaitis, Elisabeth I. Heath
Clinical Cancer Research. 2017-09-01 - 20 citationsTwo Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer.Jeffrey R. Infante, Amita Patnaik, Claire F. Verschraegen, Anthony J. Olszanski, Montaser Shaheen
Cancer Chemotherapy and Pharmacology. 2017-01-17
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
